Article
EGFR FISH versus mutation: different tests, different end-points.
Lung cancer (Amsterdam, Netherlands) - 1 May 2008
Cappuzzo Federico
Abstract excerpt
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) demonstrated to significantly improve survival of non-small cell lung cancer patients (NSCLC) previously exposed to chemotherapy. Although clinical features, particularly smoking history, help physicians for identifying the s...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
